stock decline

Trade Desk beat Q4 earnings expectations but shares tumbled 14.67% after providing weak forward guidance, signaling management caution on near-term advertising demand.

USA Rare Earth stock plunged 41% from October peak as production timelines extend, with magnet factory opening delayed to mid-2026 and mining production pushed to 2028.

Fermi Inc. faces securities lawsuit alleging misleading statements about Project Matador AI data center. Stock fell 59% after primary tenant terminated $150M funding agreement.

American Express stock dropped 12% despite strong 2025 earnings growth and positive 2026 guidance, suggesting market concerns about credit quality and macro risks.

Infleqtion shares fell 7% below their IPO opening price after completing a SPAC merger, now trading at 52-week lows amid broader market weakness and typical post-merger price discovery.

Steven Madden beat Q4 earnings estimates with strong DTC growth, but withheld 2026 guidance citing tariff uncertainty and acquisition costs, causing shares to decline 6.56%.

Securities firm investigating ODDITY Tech after algorithmic glitch disrupted major ad partner, causing stock decline. Probe examines if company disclosed material information timely and adequately.

Duolingo stock plummeted 38% year-to-date after weak Q4 guidance and the company's shift to prioritize user growth over revenue, sparking investor concerns about near-term performance.

Carvana stock dropped 10% post-earnings as profitability concerns persist despite 58% revenue growth. Compressed margins and missed EBITDA expectations weigh on investor sentiment.

uniQure faces securities fraud lawsuit after FDA rejected its drug candidate AMT-130, causing a 49% stock plunge. Plaintiffs allege the company failed to disclose material information to investors.

Corcept Therapeutics faces securities fraud lawsuit for failing to disclose FDA setback on relacorilant drug, causing 50% stock decline.

Law firm files securities fraud lawsuit against BellRing after 52% stock plunge, alleging failure to disclose inventory and supply chain issues.

Ancient Art L.P. sold 700,000 Frontier Group shares worth $3.1M in Q4, reducing its stake while maintaining 3.82% ownership amid airline sector challenges.

Inovio Pharmaceuticals faces class action lawsuit over alleged false statements regarding manufacturing defects and regulatory prospects after FDA rejected accelerated approval, causing 24% stock decline.

Class action filed against BellRing for allegedly misrepresenting sales growth through customer inventory buildup. Stock fell 33% after weaker-than-expected 2025 outlook disclosure.

Law firm investigates Franklin BSP Realty Trust for potential securities violations after missing earnings expectations and reporting significant asset liquidation delays, triggering a 14% stock decline.

Pomerantz files class action lawsuit against Bath & Body Works for alleged securities violations following missed earnings and stock decline in 2025.

IBM shares fell 13% as AI tools threaten its legacy modernization business, which represents 23% of revenue. Investors worry about automation disrupting this critical earnings stream.

American Sports shares dropped 4.42% despite beating Q4 earnings, as weak 2026 guidance disappointed investors seeking stronger growth outlook.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and concealed business risks during 2025, following merger collapse and infrastructure delays.